Cupps Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BFA
O
TCM
CCA
Cupps Capital Management's RGEN Position: Q3 2016 in Review
Cupps Capital Management reduced its Repligen (RGEN) stake by 87% in Q3 2016, selling an estimated $862K and leaving 4,414 shares worth $133K. The position accounts for 0.06% of the portfolio, ranked #141.
Cupps Capital Management first reported a position in RGEN in Q2 2014 and has held it in 7 quarters since. The position peaked at $6.33M in Q1 2015. 182 funds tracked by Wall St. Rank hold RGEN as of Q3 2016.
- Cupps Capital Management held 4,414 shares of Repligen worth $133K as of Q3 2016.
- Cupps Capital Management sold 28,556 Repligen shares in Q3 2016, an estimated $862K.
- Repligen made up 0.06% of Cupps Capital Management's portfolio in Q3 2016, its #141 holding.
- Cupps Capital Management first reported a position in Repligen in Q2 2014 and has held it in 7 quarters since.
- Cupps Capital Management's Repligen position peaked at $6.33M in Q1 2015.
- 182 funds tracked by Wall St. Rank held Repligen as of Q3 2016.
Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.